Acylin Therapeutics Receives $2,000,000 Series A Financing
-
Feed Type
-
Link
http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=51fe9757-8b1c-4c44-ba70-98aa456cab01&Preview=1 -
Date
6/4/2012 -
Company Name
Acylin Therapeutics -
Mailing Address
1616 Eastlake Ave Seattle, WA 98102 -
Company Description
The company develops cancer, metabolic and disease therapies. -
Website
Undisclosed
-
Transaction Type
Venture Equity -
Transaction Amount
$2,000,000 -
Transaction Round
Series A -
Proceeds Purposes
Proceeds purposes were not disclosed. SEC regulatory filing. -
M&A Terms
-
Venture Investor
Undisclosed
